Stay updated with breaking news from ஏஞ்சலா மார்குசி. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
DBV Technologies S.A.: DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference DBV Technologies to Participate in the H.C. Wainwright Global Life Sciences Conference DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that Daniel Tassé, Chief Executive Officer, will present at the H.C. Wainwright Global Life Sciences Conference being held March 9-10, 2021. A webcast of the presentation at the H.C. Wainwright Healthcare Conference will be available on the Investors & Media section of the Company s website beginning Tuesday, March 9 th at 7:00 a.m. ET: ....
France: 0805 102 604 A live webcast of the call will be available on the Investors & Media section of the Company s website: https://www.dbv-technologies.com/investor-relations/. A replay of the presentation will also be available on DBV s website after the event. About DBV Technologies DBV Technologies is developing Viaskin™, an investigational proprietary technology platform with broad potential applications in immunotherapy. Viaskin is based on epicutaneous immunotherapy, or EPIT™, DBV s method of delivering biologically active compounds to the immune system through intact skin. With this new class of non-invasive product candidates, the Company is dedicated to safely transforming the care of food allergic patients. DBV s food allergies programs include ongoing clinical trials of Viaskin Peanut. DBV Technologies has global headquarters in Montrouge, France and offices in Bagneux, France, and North American operations in Summit, NJ and New York, NY. The Co ....
DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.
DBV Technologies S.A.: DBV Technologies Announces Date Change for Reporting Full Year 2020 Financial Results finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.
DBV Technologies S.A.: DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021 DBV Technologies to Report Full Year 2020 Financial Results on March 4, 2021 DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company, today announced that the Company will host a conference call and live audio webcast on Thursday, March 4, 2021, at 5:00 p.m. ET/23:00 CET to report full year 2020 financial results and provide a corporate update. This call is accessible via the below teleconferencing numbers, followed by the reference ID: 50114481. United States: (866) 866-1333 France: 0805 102 604 A live webcast of the call will be available on the Investors & Media section of the Company s website: ....